Cardiovascular events with increased lipoprotein-associated phospholipase A(2) and low high-density lipoprotein-cholesterol: the Veterans Affairs HDL Intervention Trial.
about
Lipoprotein-associated phospholipase A2 prognostic role in atherosclerotic complicationsAntioxidant and inflammatory aspects of lipoprotein-associated phospholipase A₂ (Lp-PLA₂): a reviewLipoprotein-associated phospholipase A2 as a novel risk marker for cardiovascular disease: a systematic review of the literatureDietary, lifestyle, and clinical predictors of lipoprotein-associated phospholipase A2 activity in individuals without coronary artery disease.Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies.Lp-PLA2 Inhibitors for the Reduction of Cardiovascular EventsWhy does a high-fat diet induce preeclampsia-like symptoms in pregnant rats.Integrative Treatments to Reduce Risk for Cardiovascular DiseaseAre Additional Lipid Measures Useful?Systematic Review of the Association between Lipoprotein-Associated Phospholipase A2 and AtherosclerosisLipoprotein-associated phospholipase A2: a cardiovascular risk predictor and a potential therapeutic target.Recent developments with lipoprotein-associated phospholipase A2 inhibitors.Elevated plasma platelet-activating factor acetylhydrolase activity and its relationship to the presence of coronary artery disease.Lipoprotein-associated phospholipase A2, and subsequent cardiovascular events and mortality among patients with coronary heart disease.Therapeutic Options to Reduce Lp-PLA2 Levels and the Potential Impact on Vascular Risk Reduction.Food patterns, inflammation markers and incidence of cardiovascular disease: the Malmö Diet and Cancer study.Association of lipoprotein-associated phospholipase A2 and endothelial function in the Multi-Ethnic Study of Atherosclerosis (MESA)
P2860
Q26777871-0891273C-714B-4A9A-94D9-543798682C9BQ26991853-991B354A-1D55-4992-805C-A44459D18774Q33536648-E18A7771-1B6A-4F4E-8B56-39DBB9DAFEA6Q33666216-E3A61D25-381E-4F0F-A28D-6695D0753DB6Q33829154-FDADAFBD-6FC2-4D9B-8C0E-791A14383451Q33936097-BC4EB83B-D41F-4F24-9722-2984B9586833Q34094810-211E7341-CC52-4C80-A537-FF815473BD8BQ34730309-610ECD25-4AAE-4507-9BB8-DED84D9C8EB1Q34730419-5A341BD4-B971-456C-BE73-3D306E90718CQ35764402-D642DCA1-C7C0-4FA1-8E27-DE63D46D6ED3Q37445865-23D33885-5CBF-40AC-8733-903F334F4A74Q37738359-951D1F44-04D4-4947-AAFD-33B7DAE03071Q39050736-54A6CB7D-24CD-4989-8C04-BA8F89C0C3B4Q40789562-989E4EB1-6C5F-4028-85C8-F525ECE1C761Q44652488-74249189-4F1E-496F-9A61-BAD6F407AA9EQ46616467-383416A8-F9B2-4CBA-86B6-891F02F876C3Q57616453-BEAC7D41-CC58-4D1E-A834-BE8696B66672
P2860
Cardiovascular events with increased lipoprotein-associated phospholipase A(2) and low high-density lipoprotein-cholesterol: the Veterans Affairs HDL Intervention Trial.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Cardiovascular events with increased lipoprotein-associated phospholipase A
@nl
Cardiovascular events with inc ...... ffairs HDL Intervention Trial.
@en
type
label
Cardiovascular events with increased lipoprotein-associated phospholipase A
@nl
Cardiovascular events with inc ...... ffairs HDL Intervention Trial.
@en
prefLabel
Cardiovascular events with increased lipoprotein-associated phospholipase A
@nl
Cardiovascular events with inc ...... ffairs HDL Intervention Trial.
@en
P2093
P1476
Cardiovascular events with inc ...... Affairs HDL Intervention Trial
@en
P2093
Bela F Asztalos
Dorothea Collins
Jeanenne J Nelson
Sander J Robins
P304
P356
10.1161/ATVBAHA.107.160739
P407
P577
2008-03-20T00:00:00Z